Neurones Balance Sheet Health

Financial Health criteria checks 5/6

Neurones has a total shareholder equity of €399.0M and total debt of €11.2M, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are €679.4M and €280.5M respectively. Neurones's EBIT is €73.6M making its interest coverage ratio -10.7. It has cash and short-term investments of €268.1M.

Key information

2.8%

Debt to equity ratio

€11.21m

Debt

Interest coverage ratio-10.7x
Cash€268.12m
Equity€398.95m
Total liabilities€280.50m
Total assets€679.45m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: NE9's short term assets (€546.3M) exceed its short term liabilities (€243.4M).

Long Term Liabilities: NE9's short term assets (€546.3M) exceed its long term liabilities (€37.1M).


Debt to Equity History and Analysis

Debt Level: NE9 has more cash than its total debt.

Reducing Debt: NE9's debt to equity ratio has increased from 0% to 2.8% over the past 5 years.

Debt Coverage: NE9's debt is well covered by operating cash flow (554.5%).

Interest Coverage: NE9 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies